By the editorial team · · Disclosed sponsored placement
The link above is a contextual, do-follow editorial link placed inside a real article on a publication we own and operate.
Adsy alternative
Owned portals with transparent metrics instead of a third-party publisher marketplace lottery.
Pick a niche and tap Match portals to see the owned publications in our network that fit your target.
owned portals matched · open one to preview the placement
Adsy is a useful marketplace that connects buyers with third-party site owners who accept guest posts, giving you a large catalog, self-serve ordering, and a range of price points. If you want choice and the ability to shop many publishers in one place, it is a convenient platform.
BacklinkPlace replaces the publisher lottery with owned, controlled supply. Rather than buying from independent site owners whose data and standards vary, you browse our own niche editorial portals by live Domain Rating and Google Analytics traffic, then we write, publish, and report the contextual do-follow link on inventory we operate. You get a verifiable audience, a guaranteed placement on a calendar we set, one editorial standard, FTC sponsored disclosure, and white-hat digital PR with no PBNs and no ranking promises.
Side by side
Adsy is a trademark of its owner, referenced nominatively for comparison. Pricing and feature descriptions are approximate and may change; check each provider for current details.
FAQ
Yes, if you want owned portals with verifiable DR and Google Analytics traffic and a guaranteed placement, rather than buying from third-party publishers whose data varies. Adsy offers wide marketplace choice; BacklinkPlace leads with transparent, controlled inventory.
Adsy uses roughly per-post marketplace pricing set by each publisher, often with low floors. BacklinkPlace prices each placement by niche, DR, and live traffic on our owned portals, on transparent B2B plans with no free tier, so the metrics are verifiable.
Adsy alternative
Verifiable DR and traffic, guaranteed placement, FTC-disclosed editorial. Cancel anytime.